Ten63 Therapeutics
Swati completed her Ph.D. in Computational Biology and Bioinformatics from Duke University in 2015, and did her postdoc at New York University. Her work pioneered the use of combinatorial design techniques for nucleic acids. Furthermore, her research experience includes developing methodologies for macromolecular structure prediction and design, and x-ray structure validation. Fun fact: she dabbles with acrylic painting and likes to collect hardbound books of famous scifi and fantasy novels.
This person is not in any offices
Ten63 Therapeutics
Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world’s most lethal diseases.